Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference
Heartflow (NASDAQ:HTFL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $39.00 to $40.00. They now have a "buy" rating on the stock.
Heartflow (NASDAQ:HTFL) had its price target raised by analysts at JPMorgan Chase & Co. from $36.00 to $40.00. They now have an "overweight" rating on the stock.
Heartflow (NASDAQ:HTFL) had its price target raised by analysts at Stifel Nicolaus from $35.00 to $40.00. They now have a "buy" rating on the stock.
Heartflow Reports Third Quarter 2025 Financial Results